Approval · Notice of Compliance 31286 · 2023
BUTRANS: Notice of Compliance 31286
Issued July 24, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31286
- Date
- July 24, 2023
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM), and Package Insert (PI). Conversion of the Product Monograph to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUTRANS | Not yet assigned | — |
Medicinal ingredients
- BUPRENORPHINE 5 MCG per HR
- BUPRENORPHINE 10 MCG per HR
- BUPRENORPHINE 15 MCG per HR
- BUPRENORPHINE 20 MCG per HR